4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001127602-18-009820
Options or other derivatives
- Chief Medical Officer acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Faleck Herbert J Chief Medical Officer | 2018-03-01 | Grant or award · Stock Option (Right To Purchase) | +90,000 | 90,000 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…